Here is a rather long and confusing article. Read it if you need to be lulled to sleep. journals.physiology.org/doi... In it I found a ridiculously interesting paragraph as follows: "Deficits in regional brain iron and changes in uptake and efflux of brain iron are currently being investigated as underlying causes of RLS symptoms. MRI, ultrasound imaging, and autopsy studies have all indicated that RLS patients exhibit low brain iron, particularly in the substantia nigra (1, 14, 24, 56). Furthermore, infusion of iron dextran improves RLS symptoms and elevates substantia nigra and prefrontal cortex iron levels (22). Later studies in which a different iron complex was infused did not result in an improvement in nigral iron concentration and did not improve RLS symptoms (23)."
Sooo, iron dextran (dextrose/glucose is a monosaccharide that unlike sucrose will cross the blood brain barrier) infused into RLS patients improved their brain iron levels and their symptoms of RLS, whereas another formulation did not. Wow!
It sounds like alot of RLS patients are getting this somewhat newer Injectafer infusion, yet like iron sucrose it uses a double sugar called maltose - I believe. Sucrose and maltose do not readily cross the blood brain barrier from what I read, but I could be confused. The absolute newest infusion uses Feraheme which sounds like the iron protein is in colloidial (small particle) form and uses glucose as a coating. BINGO...don't you think? The smaller the drug particle in size, weight and bonds the more readily it crosses the blood brain barrier.
And where do we want that iron to go...